Journal of Fungi
In Vitro Terbinafine Susceptibility of Dermatophytes and Mycological Cure Outcomes from a Multicenter Phase III Onychomycosis Trial
Por Mahmoud Ghannoum, Erin Marie D. San Valentin y Amir Tavakkol.
Contenido en inglés
Resumen
Background
Dermatophyte infections, including onychomycosis, affect millions worldwide. Terbinafine, an allylamine antifungal, remains a foundational method of treatment.
Objective
We aim to evaluate the in vitro antifungal susceptibility of terbinafine against dermatophyte isolates obtained from patients participating in a Phase III onychomycosis clinical trial.